Great Point Partners has acquired a majority stake in Lenis Group, enhancing its healthcare investment portfolio. Lenis, a Slovenian firm, specializes in the commercialization and distribution of specialty pharmaceuticals in Central and Eastern Europe. With this acquisition, Lenis aims to accelerate its regional expansion and improve access to specialty medicines. Former Biogen CEO Michel Vounatsos has been appointed as Board Chairman of Lenis.
Company Information
Company
Great Point Partners
About
Great Point Partners, founded in 2003 and based in Greenwich, CT, is a leading health care investment firm with 30 professionals, investing in the United States, Canada, and Western Europe. GPP is currently making new minority and majority private equity investments from GPP IV. Great Point manages approximately $1.7B of capital (including committed and uncalled capital) in its private funds and public life sciences equity strategy (BioMedical Value Fund). Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 growing health care companies. The private equity funds invest across all sectors of the health care industry with a particular emphasis on biopharmaceutical services and supplies, alternate site care, medical device contract manufacturing and information technology enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies.
Don't miss Great Point Partners's next move
Get an email the moment Great Point Partners makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Predictive Intelligence
Strategic
ML-powered predictions for Great Point Partners's next move
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed
Frequently asked
Who acquired Lenis Group?
Lenis Group was acquired by Great Point Partners. The deal was reported on December 10, 2025. Great Point Partners, founded in 2003 and based in Greenwich, CT, is a leading health care investment firm with 30 professionals, investing in the United States, Canada, and Western Europe. Great Point Partners is privately held and operates in Biotechnology.
When did Great Point Partners acquire Lenis Group?
Great Point Partners's acquisition of Lenis Group was reported on December 10, 2025. Great Point Partners has acquired a majority stake in Lenis Group, enhancing its healthcare investment portfolio. Lenis, a Slovenian firm, specializes in the commercialization and distribution of specialty pharmaceuticals in Central and Eastern Europe. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Lenis Group do?
Lenis Group is a full-service specialty pharmaceutical commercialization and distribution partner. Founded in 2008, it services Central and Eastern Europe with a focus on niche and specialty Rx medicines. It is privately held, operating in Biotechnology, and is based in Slovenia.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
SloveniaBiotechnologyHealth CareVenture CapitalBiotechnologyHealth CarePharmaceutical